Cleared Traditional

K971329 - CTF SYSTEMS INC, WHOLE-CORTEX MEG SYSTEM (WITH OPTIONAL EEG SUBSYSTEM)

K971329 is an FDA 510(k) clearance for CTF SYSTEMS INC, manufactured by Ctf Systems, Inc.. The device is a Class 2 Neurology device with product code GWQ cleared through the Traditional 510(k) pathway after a 224-day FDA review.

K971329 · Ctf Systems, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1997
Decision
224d
Days
Class 2
Risk

K971329 is an FDA 510(k) clearance for the CTF SYSTEMS INC, WHOLE-CORTEX MEG SYSTEM (WITH OPTIONAL EEG SUBSYSTEM). Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Ctf Systems, Inc. (Port Coquitlam, B.C., CA). The FDA issued a Cleared decision on November 20, 1997 after a review of 224 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ctf Systems, Inc. devices

FDA 510(k) Submission Details - K971329

510(k) Number K971329 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 1997
Decision Date November 20, 1997
Days to Decision 224 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d slower than avg
Panel avg: 148d · This submission: 224d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWQ Device Classification - Class 2, Special Controls

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 137
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K971329.
EXCEL NEURO WORKS
K980214 · Excel Tech. , Ltd. · Apr 1998
BIO-LOGIC CEEGRAPH 128-CHANNEL RECORDING SYSTEM
K973883 · Bio-Logic Systems Corp. · Mar 1998
NEUROAMP EEG AMPLIFIER
K974495 · Neurocorp, Ltd. · Feb 1998
DEEG-LITE
K972202 · Grass-Telefactor Product Group · Jul 1997
SATELLITE
K971331 · Nicolet Biomedical, Inc. · Jun 1997
MODEL 1320, NEUROLINK II NEUROMONITORING SYSTEM
K970942 · Physiometrix, Inc. · Jun 1997